Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study
Titel:
Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study
Auteur:
Artaç, Mehmet Çoşkun, Hasan Şenol Korkmaz, Levent Koçer, Murat Turhal, Nazım Serdar Engin, Hüseyin Dede, İsa Paydaş, Semra Öksüzoğlu, Berna Bozcuk, Hakan Demirkazık, Ahmet